Bibliography

Found 7 results

Filters: Keyword is Internal and Author is M E Mallory [Clear All Filters]

2002

Langford D, Sanders VJ, Mallory ME, Kaul M, Masliah E. Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. Journal of Neuroimmunology [Internet]. 2002 ;127(1-2):115-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12044982

Hashimoto M, Sagara Y, Langford D, Everall I, Mallory ME, Everson A, Digicaylioglu M, Masliah E. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection. The Journal of Biological Chemistry [Internet]. 2002 ;277(36):32985-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12095987

Everall I, Bell C, Mallory ME, Langford D, Adame A, Rockestein E, Masliah E. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Molecular and Cellular Neurosciences [Internet]. 2002 ;21(13):493-501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12498789

Langford TD, Letendre S, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald SL, Jernigan T, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (London, England) [Internet]. 2002 ;16(7):1019-29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11953468

2001

Everall I, Trillo-Pazos G, Bell C, Mallory ME, Sanders VJ, Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. Journal of Neuropathology and Experimental Neurology [Internet]. 2001 ;60(3):293-301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11245213

2000

Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS (London, England) [Internet]. 2000 ;14:69-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10714569

1999

Everall I, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory ME, Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathology (Zurich, Switzerland) [Internet]. 1999 ;9(2):209-217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10219738